Limits claims brought by political subdivisions against certain entities who are parties to a statewide opioid settlement agreement
Summary
Senate Bill 985, introduced by Senator Rehder, aims to amend existing state laws regarding legal claims associated with opioid settlements. The bill adds two new sections to Chapter 196 of the Revised Statutes of Missouri, outlining definitions and procedures related to statewide opioid settlement agreements. A significant provision of this bill prohibits political subdivisions, such as counties and cities, from asserting claims against entities involved in these settlements. This change is intended to streamline the settlement process and minimize frictions between state and local governments in the legal context surrounding opioid litigation.
The essence of SB985 revolves around limiting the authority of local political subdivisions to pursue claims regarding opioids once a statewide settlement agreement has been reached. By doing so, the bill seeks to consolidate the legal process under the supervision of the attorney general. This action suggests a legislative intent to provide a uniform approach to handling opioid-related claims, which have historically seen numerous local and independent legal initiatives that could complicate or dilute the responsibilities shared among state entities.
A notable point of contention within discussions around SB985 could emerge from the balance between state authority and local autonomy. Critics might argue that this legislation infringes upon the ability of local governments to address specific community needs arising from the opioid crisis, potentially leading to disputes over resource allocation and local public health strategies. This could especially resonate in communities that feel disproportionately impacted by opioid misuse and its consequences.
An emergency clause included in this bill emphasizes its urgency due to the ongoing opioid crisis, indicating that swift legislative action is necessary to preserve public welfare. By ensuring that political subdivisions cannot pursue individual claims against opioid manufacturers or distributors, SB985 is presented as a critical measure for freeing up resources and clarifying partnerships at the state level aimed at combating opioid-related issues effectively.
Clarifies that certain provisions related to statewide opioid settlement agreements shall cover settlements and releases related to any entities involved in the prescription drug marketing, supply and payment chain that may have contributed to the opioid epidemic through illegal conduct.
Includes interest earned on the monies obtained by the state through the statewide opioid settlement agreement, in the opioid settlement fund; requires any New York subdivision that receives funds pursuant to an opioid settlement agreement to spend interest earned on such funds on approved uses.
Includes interest earned on the monies obtained by the state through the statewide opioid settlement agreement, in the opioid settlement fund; requires any New York subdivision that receives funds pursuant to an opioid settlement agreement to spend interest earned on such funds on approved uses.
Bars public entities and public employees from entering into confidential settlements of claims against them; provides that such settlements constitute public records.
Relating to limitations on the use of public money under certain economic development agreements or programs adopted by certain political subdivisions.